Ingeniospec v. Ampere (337-TA-1383): ITC Smart Eyewear Patent Case Settles
Ingeniospec LLC brought an ITC Section 337 infringement action against Ampere LLC asserting four patents covering smart eyewear components — including printed circuit boards, radiation detection systems, and extended endpieces. The case settled after 343 days, before any exclusion order issued.
Four smart eyewear patents, one ITC action, settled in under a year
On 20 November 2023, Ingeniospec LLC filed ITC Investigation No. 337-TA-1383 before Administrative Law Judge Cameron Elliot in Washington DC, asserting four US patents — US10310296B2, US11803069B2, US8770742B2, and US11762224B2 — against Ampere LLC. The patents collectively cover wearable eyewear integrating electrical components via extended endpieces, connection regions, printed circuit boards, and radiation detection systems, representing a layered portfolio in the emerging smart eyewear hardware space.
The investigation was terminated on 28 October 2024 on the basis of a settlement between the parties. No exclusion order, limited exclusion order, or consent order appears in the public record, which is consistent with a private resolution negotiated before the ITC reached a merits determination. The settlement extinguishes the immediate Section 337 threat for Ampere without a public finding of infringement or validity on any of the four asserted patents.
At 343 days, the case resolved notably faster than the ITC’s historical average investigation length of approximately 16 months, suggesting settlement talks may have progressed in parallel with early procedural stages. What drove the resolution — licensing terms, design-around commitments, or commercial considerations — remains confidential. The absence of any public claim construction or infringement ruling leaves the scope of all four patents legally untested at the ITC level.
Filing to Case Settled in 343 days
343 days — faster than the typical ITC 337 investigation average of ~16 months
Case settled: what the ITC termination means for both parties
ITC Section 337 settlement terminates investigation
A settlement at the ITC terminates the investigation without a finding on the merits — no exclusion order issues and no infringement or validity determination is recorded. The Commission closes the investigation upon confirming the settlement resolves the Section 337 matter. This is a procedural endpoint, not a substantive ruling, and the patents remain fully enforceable in other forums.
No merits ruling issuedSettlement terms are private — public record is silent on conditions
ITC settlements are typically embodied in private agreements filed under seal or referenced only in termination orders. The public record does not disclose whether Ingeniospec received a license, royalties, or design-around commitments from Ampere. Observers cannot infer a win or loss for either party from the termination notice alone. The distinction matters: a licensed settlement preserves patent value; a walk-away settlement may suggest leverage limitations.
Private settlement termsIngeniospec’s patents remain intact and enforcement options open
Because no invalidity finding was entered, all four patents — US10310296B2, US11803069B2, US8770742B2, and US11762224B2 — survive the ITC action with their claims legally untested. Ingeniospec retains the right to assert the same patents in US district court or future ITC investigations against other smart eyewear manufacturers. A settlement at this stage is consistent with a patent holder who secured value without litigation risk.
Patents remain enforceableSmart eyewear sector faces unresolved ITC exposure on these patents
The settlement leaves the claims of all four patents uninterpreted in the public record, which typically heightens uncertainty for other companies in the smart eyewear hardware space. Competitors producing eyewear with integrated PCBs, radiation detection, or extended endpiece electrical connections cannot rely on a prior invalidity ruling as a shield. The Ingeniospec portfolio may represent a continuing enforcement risk across the sector.
Sector-wide claim uncertaintyFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Ingeniospec, LLC | Company | Smart eyewear patent licensing entity — holder of US10310296B2 and three related patentsSearch in Eureka ↗ |
| Defendant | Ampere, LLC | Company | Ampere LLC — respondent in ITC 337 action concerning smart eyewear hardwareSearch in Eureka ↗ |
| Plaintiff counsel | Evan Langdon | Attorney | Counsel for Ingeniospec, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Fabricant LLP | Law Firm | Representing Ingeniospec, LLCSearch in Eureka ↗ |
| Presiding judge | Judge Cameron Elliot | Judge | United States International Trade CommissionSearch in Eureka ↗ |
Official order — verbatim text
The termination notice records ‘Participant Disposition: Settlement’ with a basis of ‘Case Settled.’ This language confirms a consensual resolution between Ingeniospec and Ampere but discloses no substantive terms. At the ITC, a settled investigation leaves all asserted claims — across all four patents — legally unconstrued and technically unchallenged on the merits. Neither party is bound by an infringement finding, and no invalidity determination limits future assertion of this portfolio.
US10310296B2 — Smart eyewear with extended endpieces for electrical components
The four asserted patents — US10310296B2, US11803069B2, US8770742B2, and US11762224B2 — form a layered portfolio protecting the integration of electronic functionality into spectacle frames. Collectively they address the mechanical and electronic architecture of smart eyewear: how electrical components are mounted via extended endpieces, how a connection region routes signals, how a PCB is embedded in the frame, and how a radiation detection system is incorporated. The application dates span from early-generation wearable designs through to recent continuation filings, suggesting a prosecution strategy designed to extend coverage as the technology matured.
For the smart glasses and AR eyewear sector, this portfolio is commercially significant. The claims appear to address foundational structural approaches to embedding electronics in spectacle form factors — precisely the challenge facing every OEM developing lightweight wearable displays, health-monitoring eyewear, or protective smart glasses. If the broadest claims withstand scrutiny, competitors face a material FTO obstacle. The absence of any invalidity ruling from the ITC proceeding means no prior art challenge has been publicly tested against these claims.
Should your team run an FTO against US10310296B2 and the Ingeniospec portfolio?
Any company designing, manufacturing, or importing eyewear that integrates electrical components — including AR glasses, health-monitoring frames, UV/radiation-sensing eyewear, or PCB-embedded smart glasses — should treat this four-patent portfolio as a priority FTO target. The ITC settlement with Ampere confirms active enforcement intent. The lack of any public claim construction means scope uncertainty is high, and broad claims may read on a wider range of products than first apparent.
PatSnap Eureka’s FTO Search Agent can map each of the four Ingeniospec patents against your product architecture, identify relevant prior art that was not cited during prosecution, and flag claim elements most likely to create infringement risk. Eureka’s AI-assisted analysis covers continuation relationships and cross-references prosecution history, helping R&D and IP teams build a defensible clearance position before committing to a product launch or import strategy.
Run a freedom-to-operate analysis on US10310296B2 to assess your product’s exposure
Run FTO in Eureka →Similar ITC Section 337 cases involving smart eyewear and wearable electronics patents
Browse ITC 337 investigations and district court actions involving wearable display, smart glasses, and integrated eyewear electronics patents before the US International Trade Commission.
What this case signals for the smart eyewear IP landscape
A fast ITC settlement on four wearable eyewear patents leaves claim scope unresolved and enforcement risk live for the broader industry.
ITC Section 337 remains a high-leverage tool for hardware patent holders
Ingeniospec’s use of the ITC — rather than district court — signals a deliberate enforcement strategy. The threat of import exclusion compresses settlement timelines and shifts negotiating leverage toward the patent holder. Companies importing smart eyewear hardware into the US should treat ITC risk as a first-order concern when assessing FTO.
Four-patent portfolio assertion raises claim-construction complexity for defendants
Asserting four patents covering overlapping eyewear hardware features — PCBs, endpieces, connection regions, radiation detection — forces respondents to defend on multiple claim fronts simultaneously. This portfolio layering is a common tactic to increase settlement pressure and reduce the likelihood of a clean design-around. Competitors should map each patent independently.
Ingeniospec v Ampere — key questions answered
Ingeniospec asserted four patents: US10310296B2 (eyewear with extended endpieces for electrical components), US11803069B2 (eyewear with connection region), US8770742B2 (eyewear with printed circuit board), and US11762224B2 (eyewear with radiation detection system). All four remained legally unconstrued at the time of settlement.
The investigation was terminated on 28 October 2024 after the parties reached a private settlement. No exclusion order, limited exclusion order, or consent order was issued. The ITC recorded the basis of termination as ‘Case Settled,’ with no public disclosure of financial terms or licensing conditions.
A settlement at the ITC does not constitute a merits ruling. Ingeniospec’s four patents survive with no invalidity finding on record, leaving all claims fully enforceable. The patent holder retains the right to assert the same patents against other parties in US district court or in future ITC investigations.
The ITC can issue exclusion orders barring infringing imports at the US border, which is a powerful remedy for hardware products manufactured overseas. Section 337 investigations also proceed on a faster schedule than district court litigation, compressing timelines and increasing settlement pressure on respondents who rely on import supply chains.
Ingeniospec was represented by Fabricant LLP, with Evan Langdon listed as plaintiff agent. No defendant law firm or agent is recorded in the public case data for Ampere LLC. The case was assigned to Administrative Law Judge Cameron Elliot.
PatSnap Eureka searches patents and litigation data to answer instantly.